חזרה לתוצאות החיפוש

Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Pancreatic Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • University of Colorado, Aurora, Colorado, United States

  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Sana Karam, M.D., Ph.D.) · sanadkaram@wustl.edu · 314-273-3240
    Contact: Principal Investigator (Sana Karam, M.D., Ph.D.)
    Roheena Panni, M.D. (Sub-investigator)
    Kian-Huat Lim, M.D. (Sub-investigator)
    Michael Waters, M.D., Ph.D. (Sub-investigator)
    Nikolaos Andreatos, M.D. (Sub-investigator)
    Olivia Aranha, M.D., Ph.D. (Sub-investigator)
    Patrick Grierson, M.D., Ph.D. (Sub-investigator)
    Joseph Harms, Ph.D., DABR (Sub-investigator)
    Ramon Jin, M.D., Ph.D. (Sub-investigator)
    Moh'd Khushman, M.D. (Sub-investigator)
    Chunjie Li, M.D., Ph.D. (Sub-investigator)
    Trang Nguyen, M.D. (Sub-investigator)
    Caron Rigden, M.D. (Sub-investigator)
    Dominic Sanford, M.D. (Sub-investigator)
    Mark Sundermeyer, M.D. (Sub-investigator)
    Rama Suresh, M.D. (Sub-investigator)
    Ben Tan, M.D. (Sub-investigator)
    Junxiao Hu, Ph.D. (Sub-investigator)
מובילי המחקר

  • Sana Karam, M.D., Ph.D.

    Principal Investigator

    Washington University School of Medicine

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)